SCHEMBL21301465

SCHEMBL21301465

Cc1ccc2oc(C3=Cc4ccc(N5CCN(C)CC5)cc4OC3=C3CC3)cc2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
GLA P06280 1/20 0.34
KMT2A Q03164 1/20 0.34
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
HTR3A P46098 2/20 0.33
HRH4 Q9H3N8 1/20 0.32
MAPT P10636 2/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
PTK2B Q14289 1/20 0.32
DRD2 P14416 2/20 0.32
DRD4 P21917 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15066070 0.71 ALK (0.42) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL21301415 0.69 KDM4E (0.32) KDM4ENPC1RAB9ASMN1; SMN2HTT
SCHEMBL22860335 0.68 KDM4E (0.59) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL15086289 0.68 HTR6 (0.37) ADRA2AADRA2BADRA2CHRH4HTR6
SCHEMBL23010436 0.63 KDM4E (0.51) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL23010432 0.61 KDM4E (0.59) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL15066627 0.61 ALK (0.42) HTR3AHTR6HTR3EHTR3BHTR3D
SCHEMBL31730808 0.60 KDM4E (0.49) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL23010434 0.60 HTR3A (0.54) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL5776260 0.60 MAOB (0.56) KDM4ENPC1RAB9ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797592-B1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY PTC THERAPEUTICS INC (US) 2019-08-28 EP disclosed